SEC Tracker
Get the app

Intelligent Bio Solutions INBS

Intelligent Bio Solutions reports record Q1 revenue of $1.39 million

Intelligent Bio Solutions (INBS) filed an 8-K with the SEC on Nov 10, 2026, 4:31 pm ET. Source: the filing on SEC EDGAR.

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Revenue up 25% year-over-year to $1.39 million
  2. Cartridge sales grew 32% to $845,583, 61% of total revenue
  3. Gross profit margin expanded to 54.5%
  4. Submitted FDA 510(k) premarket notification for drug screening system

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Intelligent Bio Solutions files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.